USA Cardiovascular Devices Market Trends and Forecast (2010 - 2015)
One in three American adults has some form of Cardiovascular Disease (CVD). Heart disease and stroke are the most common cardiovascular diseases. These are the first and third leading causes of death for both men and women in the United States. Cardiovascular Disease includes high blood pressure, coronary heart disease, heart failure and stroke. It is the leading cause of death in America and the World.
United States cardiovascular devices market is expected to be over US$ 35 Billion by 2015, with a compound annual growth rate of approximately 7% from the period of 2011 to 2015. The cardiovascular device market is expected to be driven by increase in the incidence of cardiovascular diseases, an ageing population and greater adoption of technological advancements.
The most rapidly growing segments in the cardiovascular device market are interventional cardiology, cardiac rhythm management, and cardiovascular prosthetic device market. Cardiac Rhythm Management devices market is one of the major contributing segments expected to generate more than US$ 16 Billion by 2015. Interventional cardiology devices represent one of the fastest developing areas in the overall cardiovascular device market which is expected to touch US$ 12 Billion by 2015.
An increasing demand for minimally invasive surgeries amongst the rapidly aging population is expected to spark further growth in the cardiovascular devices market. Moreover, the cost efficiencies offered by lesser invasive methods expect to garner much favor amongst the healthcare payers in the coming years.
Report Details
“USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:
This section covers the key facts about the major companies that play an important role in United States Cardiovascular Market. The key companies analyzed in this section are Sorin Group, Medtronic, St. Edwards Life Science and St. Jude Medical. All the companies have been analyzed from three points 1) Revenue of the company from cardiovascular device segment globally 2) Strength of the company in cardiovascular device segment 3) Weakness of the company in cardiovascular device segment.
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
United States cardiovascular devices market is expected to be over US$ 35 Billion by 2015, with a compound annual growth rate of approximately 7% from the period of 2011 to 2015. The cardiovascular device market is expected to be driven by increase in the incidence of cardiovascular diseases, an ageing population and greater adoption of technological advancements.
The most rapidly growing segments in the cardiovascular device market are interventional cardiology, cardiac rhythm management, and cardiovascular prosthetic device market. Cardiac Rhythm Management devices market is one of the major contributing segments expected to generate more than US$ 16 Billion by 2015. Interventional cardiology devices represent one of the fastest developing areas in the overall cardiovascular device market which is expected to touch US$ 12 Billion by 2015.
An increasing demand for minimally invasive surgeries amongst the rapidly aging population is expected to spark further growth in the cardiovascular devices market. Moreover, the cost efficiencies offered by lesser invasive methods expect to garner much favor amongst the healthcare payers in the coming years.
Report Details
“USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)” report published by Renub Research provides an in-depth analysis of the past, present and future prospects. The report has been researched at source globally and features latest available data covering:
- United States Cardiovascular Device Market (2006 - 2015)
- Top 6 cardiovascular device segment (Cardiac Rhythm Management, Interventional Cardiology , Cardiovascular Surgery, Cardiovascular Prosthetic, Peripheral Vascular & Cardiovascular Monitoring & Diagnostic Device) market data from 2006 to 2015
- Top 12 cardiovascular devices (Implantable Cardioverter Defibrillator, Pacemaker, Cardiac Resynchronization Therapy-Pacemaker, Angioplasty, Angiography, PTCA Baloon, Coronary Stent, Anastomosis, Endoscopic Vessel Harvesting, Ventricular Assist Device, Heart Valve, Prothetic Heart Valve) market data from 2006 to 2015
- Mergers and Acquisitions in the Cardiovascular Device market
- Key drivers of growth in the Cardiovascular Device market
- Key Companies analysis in the Cardiovascular Device market
- More than 81 Million people are estimated to be suffering from CVD in the US
- United States cardiovascular device market is expected to over US$ 35 Billion by 2015
- Cardiac Rhythm Management devices market is one of the major contributing segments which is expected to generate more than US$ 16 Billion by 2015
- Interventional cardiology devices represent one of the fastest growing segment in the overall cardiovascular device market
- Coronary stent is the fastest growing categories in the interventional cardiology market it registered a rapid growth due to rapid advancements in the area of drug-eluting Coronary Stent
- M&A activity of cardiovascular device companies is a significant of US$ 31 Billion deals in 2006
This section covers the key facts about the major companies that play an important role in United States Cardiovascular Market. The key companies analyzed in this section are Sorin Group, Medtronic, St. Edwards Life Science and St. Jude Medical. All the companies have been analyzed from three points 1) Revenue of the company from cardiovascular device segment globally 2) Strength of the company in cardiovascular device segment 3) Weakness of the company in cardiovascular device segment.
Data Sources
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts.
Primary sources include industry surveys and telephone interviews with industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 100 paid databases.
1. EXECUTIVE SUMMARY
2. UNITED STATES CARDIOVASCULAR DEVICE MARKET & FORECAST (2006 – 2015)
3. UNITED STATES CARDIOVASCULAR DEVICE MARKET & FORECAST (2006 – 2015)
3.1 Cardiac Rhythm Management
3.1.1 Implantable Cardioverter Defibrillator
3.1.2 Pacemaker
3.1.3 Cardiac Resynchronization Therapy-Pacemaker (CRT-P)
3.2 Interventional Cardiology
3.2.1 Angioplasty
3.2.2 Angiography
3.2.3 PTCA Balloon
3.2.4 Coronary Stent
3.3 Cardiovascular Surgery
3.3.1 Anastomosis Device
3.3.2 Endoscopic Vessel Harvesting Device
3.3.3 Ventricular Assist Device (VAD)
3.3.4 Heart Valve
3.4 Cardiovascular Prosthetic Device
3.4.1 Prosthetic Heart Valve
3.5 Peripheral Vascular Device
3.6 Cardiovascular Monitoring & Diagnostic Device
4. GROWTH DRIVERS IN CARDIOVASCULAR DEVICE MARKET
4.1 Aging of the Population
4.2 Obesity
4.3 Smoking
4.4 High Incidence of Cardiovascular Death
5. CHALLENGES
5.1 Significance of Cardiovascular Device Innovation
5.2 Regulation
6. MERGER & ACQUISITION IN CARDIOVASCULAR DEVICE MARKET
7. KEY COMPANIES
7.1 Sorin
7.1.1 Globally - Sorin Revenue from Cardiovascular Devices
7.1.2 Strength
7.1.3 Weaknesses
7.2 Edwards Lifesciences
7.2.1 Global - St. Edwards Revenue from Cardiovascular Devices
7.2.2 United States - St. Edwards Revenue from Cardiovascular Devices
7.2.3 Strength
7.2.4 Weaknesses
7.3 St. Jude Medical
7.3.1 Globally - St. Jude Revenue from Medical Cardiovascular Devices
7.3.2 Strength
7.3.3 Weaknesses
7.4 Medtronic
7.4.1 Globally – Medtronic Revenue from Cardiovascular Devices
7.4.2 Strength
7.4.3 Weaknesses
2. UNITED STATES CARDIOVASCULAR DEVICE MARKET & FORECAST (2006 – 2015)
3. UNITED STATES CARDIOVASCULAR DEVICE MARKET & FORECAST (2006 – 2015)
3.1 Cardiac Rhythm Management
3.1.1 Implantable Cardioverter Defibrillator
3.1.2 Pacemaker
3.1.3 Cardiac Resynchronization Therapy-Pacemaker (CRT-P)
3.2 Interventional Cardiology
3.2.1 Angioplasty
3.2.2 Angiography
3.2.3 PTCA Balloon
3.2.4 Coronary Stent
3.3 Cardiovascular Surgery
3.3.1 Anastomosis Device
3.3.2 Endoscopic Vessel Harvesting Device
3.3.3 Ventricular Assist Device (VAD)
3.3.4 Heart Valve
3.4 Cardiovascular Prosthetic Device
3.4.1 Prosthetic Heart Valve
3.5 Peripheral Vascular Device
3.6 Cardiovascular Monitoring & Diagnostic Device
4. GROWTH DRIVERS IN CARDIOVASCULAR DEVICE MARKET
4.1 Aging of the Population
4.2 Obesity
4.3 Smoking
4.4 High Incidence of Cardiovascular Death
5. CHALLENGES
5.1 Significance of Cardiovascular Device Innovation
5.2 Regulation
6. MERGER & ACQUISITION IN CARDIOVASCULAR DEVICE MARKET
7. KEY COMPANIES
7.1 Sorin
7.1.1 Globally - Sorin Revenue from Cardiovascular Devices
7.1.2 Strength
7.1.3 Weaknesses
7.2 Edwards Lifesciences
7.2.1 Global - St. Edwards Revenue from Cardiovascular Devices
7.2.2 United States - St. Edwards Revenue from Cardiovascular Devices
7.2.3 Strength
7.2.4 Weaknesses
7.3 St. Jude Medical
7.3.1 Globally - St. Jude Revenue from Medical Cardiovascular Devices
7.3.2 Strength
7.3.3 Weaknesses
7.4 Medtronic
7.4.1 Globally – Medtronic Revenue from Cardiovascular Devices
7.4.2 Strength
7.4.3 Weaknesses
LIST OF FIGURES:
Figure 2 1: United States – Cardiovascular Device Market (Million US$), 2006 – 2010
Figure 2 2: United States – Forecast for Cardiovascular Device Market (Million US$), 2011 – 2015
Figure 3 1: United States – Cardiac Rhythm Management Market (Million US$), 2006 – 2010
Figure 3 2: United States – Forecast for Cardiac Rhythm Management Market (Million US$), 2011 – 2015
Figure 3 3: United States – Implantable Cardioverter Defibrillator Market (Million US$), 2003 – 2010
Figure 3 4: United States – Forecast for Implantable Cardioverter Defibrillator Market (Million US$), 2011 – 2015
Figure 3 5: United States – Pacemaker Market (Million US$), 2003 – 2010
Figure 3 6: United States – Forecast for Pacemaker Market (Million US$), 2011 – 2015
Figure 3 7: United States – CRT-P Market (Million US$), 2005 – 2010
Figure 3 8: United States – Forecast for CRT-P Market (Million US$), 2011 – 2015
Figure 3 9: United States – Interventional Cardiology Market (Million US$), 2006 – 2010
Figure 3 10: United States – Forecast for Interventional Cardiology Market (Million US$), 2011 – 2015
Figure 3 11: United States – Angioplasty Market (Million US$), 2003 – 2010
Figure 3 12: United States – Forecast for Angioplasty Market (Million US$), 2011 – 2015
Figure 3 13: United States – Angiography Market (Million US$), 2003 – 2010
Figure 3 14: United States – Forecast for Angiography Market (Million US$), 2011 – 2015
Figure 3 15: United States – PTCA Balloon Market (Million US$), 2003 – 2010
Figure 3 16: United States – Forecast for PTCA Balloon Market (Million US$), 2011 – 2015
Figure 3 17: United States – Coronary Stent Market (Million US$), 2003 – 2010
Figure 3 18: United States – Forecast for Coronary Stent Market (Million US$), 2011 – 2015
Figure 3 19: United States – Cardiovascular Surgery Market (Million US$), 2006 – 2010
Figure 3 20: United States – Forecast for Cardiovascular Surgery Market (Million US$), 2011 – 2015
Figure 3 21: United States – Forecast for Anastomosis Device Market (Million US$), 2011 – 2015
Figure 3 22: United States – Endoscopic Vessel Harvesting Market (Million US$), 2003 – 2010
Figure 3 23: United States – Forecast for Endoscopic Vessel Harvesting Market (Million US$), 2011 – 2015
Figure 3 24: United States – Ventricular Assist Device Market (Million US$), 2004 – 2010
Figure 3 25: United States – Forecast for Ventricular Assist Device Market (Million US$), 2011 – 2015
Figure 3 26: United States – Heart Valve Market (Million US$), 2004 – 2010
Figure 3 27: United States – Forecast for Heart Valve Market (Million US$), 2011 – 2015
Figure 3 28: United States – Cardiovascular Prosthetic Market (Million US$), 2006 – 2010
Figure 3 29: United States – Forecast for Cardiovascular Prosthetic Market (Million US$), 2011 – 2015
Figure 3 30: United States – Prosthetic Heart Valve Market (Million US$), 2008 – 2010
Figure 3 31: United States – Forecast for Prosthetic Heart Valve Market (Million US$), 2011 – 2015
Figure 3 32: United States – Peripheral Vascular Market (Million US$), 2006 – 2010
Figure 3 33: United States – Forecast for Peripheral Vascular Market (Million US$), 2011 – 2015
Figure 3 34: United States – Cardiovascular Monitoring & Diagnostic Market (Million US$), 2006 – 2010
Figure 3 35: United States – Forecast for Cardiovascular Monitoring & Diagnostic Market (Million US$), 2011 – 2015
Figure 4 1: Population Aged 60 or over: World & Development Regions, 1950 – 2050
Figure 4 2: Old-age Dependency Ratio: Major Areas, 2009 & 2050
Figure 7 1: Global – Sorin Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 2: Global – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 3: United States – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 4: Global – St Jude Medical Cardiovascular Devices Revenue (Million US$), 2007 – 2010
Figure 7 5: Global – Medtronic Cardiovascular Devices Revenue (Million US$), 2007 – 2010
Figure 2 1: United States – Cardiovascular Device Market (Million US$), 2006 – 2010
Figure 2 2: United States – Forecast for Cardiovascular Device Market (Million US$), 2011 – 2015
Figure 3 1: United States – Cardiac Rhythm Management Market (Million US$), 2006 – 2010
Figure 3 2: United States – Forecast for Cardiac Rhythm Management Market (Million US$), 2011 – 2015
Figure 3 3: United States – Implantable Cardioverter Defibrillator Market (Million US$), 2003 – 2010
Figure 3 4: United States – Forecast for Implantable Cardioverter Defibrillator Market (Million US$), 2011 – 2015
Figure 3 5: United States – Pacemaker Market (Million US$), 2003 – 2010
Figure 3 6: United States – Forecast for Pacemaker Market (Million US$), 2011 – 2015
Figure 3 7: United States – CRT-P Market (Million US$), 2005 – 2010
Figure 3 8: United States – Forecast for CRT-P Market (Million US$), 2011 – 2015
Figure 3 9: United States – Interventional Cardiology Market (Million US$), 2006 – 2010
Figure 3 10: United States – Forecast for Interventional Cardiology Market (Million US$), 2011 – 2015
Figure 3 11: United States – Angioplasty Market (Million US$), 2003 – 2010
Figure 3 12: United States – Forecast for Angioplasty Market (Million US$), 2011 – 2015
Figure 3 13: United States – Angiography Market (Million US$), 2003 – 2010
Figure 3 14: United States – Forecast for Angiography Market (Million US$), 2011 – 2015
Figure 3 15: United States – PTCA Balloon Market (Million US$), 2003 – 2010
Figure 3 16: United States – Forecast for PTCA Balloon Market (Million US$), 2011 – 2015
Figure 3 17: United States – Coronary Stent Market (Million US$), 2003 – 2010
Figure 3 18: United States – Forecast for Coronary Stent Market (Million US$), 2011 – 2015
Figure 3 19: United States – Cardiovascular Surgery Market (Million US$), 2006 – 2010
Figure 3 20: United States – Forecast for Cardiovascular Surgery Market (Million US$), 2011 – 2015
Figure 3 21: United States – Forecast for Anastomosis Device Market (Million US$), 2011 – 2015
Figure 3 22: United States – Endoscopic Vessel Harvesting Market (Million US$), 2003 – 2010
Figure 3 23: United States – Forecast for Endoscopic Vessel Harvesting Market (Million US$), 2011 – 2015
Figure 3 24: United States – Ventricular Assist Device Market (Million US$), 2004 – 2010
Figure 3 25: United States – Forecast for Ventricular Assist Device Market (Million US$), 2011 – 2015
Figure 3 26: United States – Heart Valve Market (Million US$), 2004 – 2010
Figure 3 27: United States – Forecast for Heart Valve Market (Million US$), 2011 – 2015
Figure 3 28: United States – Cardiovascular Prosthetic Market (Million US$), 2006 – 2010
Figure 3 29: United States – Forecast for Cardiovascular Prosthetic Market (Million US$), 2011 – 2015
Figure 3 30: United States – Prosthetic Heart Valve Market (Million US$), 2008 – 2010
Figure 3 31: United States – Forecast for Prosthetic Heart Valve Market (Million US$), 2011 – 2015
Figure 3 32: United States – Peripheral Vascular Market (Million US$), 2006 – 2010
Figure 3 33: United States – Forecast for Peripheral Vascular Market (Million US$), 2011 – 2015
Figure 3 34: United States – Cardiovascular Monitoring & Diagnostic Market (Million US$), 2006 – 2010
Figure 3 35: United States – Forecast for Cardiovascular Monitoring & Diagnostic Market (Million US$), 2011 – 2015
Figure 4 1: Population Aged 60 or over: World & Development Regions, 1950 – 2050
Figure 4 2: Old-age Dependency Ratio: Major Areas, 2009 & 2050
Figure 7 1: Global – Sorin Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 2: Global – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 3: United States – St Edwards Cardiovascular Devices Revenue (Million US$), 2008 – 2010
Figure 7 4: Global – St Jude Medical Cardiovascular Devices Revenue (Million US$), 2007 – 2010
Figure 7 5: Global – Medtronic Cardiovascular Devices Revenue (Million US$), 2007 – 2010
LIST OF TABLES:
Table 4 1: Global – Population aged 60 or over, 65 or over and 80 or over by Sex (Thousands)
Table 4 2: Worldwide – Prevalence of Adult Obesity for Developed Countries (Percent %), 2002 – 2005
Table 4 3: Worldwide – Prevalence of Adult Obesity for Developing Countries (Percent %), 1998 – 2005
Table 4 4: United States – Deaths from Cardiovascular Diseases (Thousand), 1900 – 2007
Table 4 5: United States – Forecast for Crude Prevalence (Percent), 2010, 2015, 2020, 2025, 2030
Table 4 6: United States – Forecast for Direct (Medical) costs (Billion US$), 2010, 2015, 2020, 2025, 2030
Table 4 7: United States – Forecast for Indirect (lost productivity) costs (Billion US$), 2010, 2015 2020, 2025, 2030
Table 6 1: Worldwide – Merger & Acquisition (Million US$), 1998 – 2010
Table 4 1: Global – Population aged 60 or over, 65 or over and 80 or over by Sex (Thousands)
Table 4 2: Worldwide – Prevalence of Adult Obesity for Developed Countries (Percent %), 2002 – 2005
Table 4 3: Worldwide – Prevalence of Adult Obesity for Developing Countries (Percent %), 1998 – 2005
Table 4 4: United States – Deaths from Cardiovascular Diseases (Thousand), 1900 – 2007
Table 4 5: United States – Forecast for Crude Prevalence (Percent), 2010, 2015, 2020, 2025, 2030
Table 4 6: United States – Forecast for Direct (Medical) costs (Billion US$), 2010, 2015, 2020, 2025, 2030
Table 4 7: United States – Forecast for Indirect (lost productivity) costs (Billion US$), 2010, 2015 2020, 2025, 2030
Table 6 1: Worldwide – Merger & Acquisition (Million US$), 1998 – 2010
